Tisdag 20 Januari | 19:48:54 Europe / Stockholm
2026-01-19 10:26:29

Hørsholm, Denmark, 19 January 2026 - ExpreS2ion Biotech Holding AB's subsidiary ExpreS2ion Biotechnologies ApS ("ExpreS2ion") is pleased to announce its participation in an upcoming investor event in January 2026, the Redeye Thematic Event: Fight Cancer.

These events represent important opportunities to showcase ExpreS2ion's innovative technology platform and exciting development pipeline to scientific and investment audiences. More details, including event registration information, are available on the Company's website and via the links below. To arrange a meeting at these events, please contact us at partnering@expres2ionbio.com or  investor@expres2ionbio.com.

21 January 2026 | Redeye Theme: Fight Cancer
Stockholm, Sweden and virtual
ExpreS2ion will participate in Redeye Theme: Fight Cancer 2026, a focused life sciences investor event highlighting Nordic companies active in oncology and cancer-related innovation. CFO Keith Alexander will present ExpreS2ion at 10:50 CET, sharing updates on the company's cancer vaccine programs and strategic priorities. For more details about the event, including how participate in person or stream the presentation, see the official event page.

Certified Adviser
Svensk Kapitalmarknadsgranskning AB